New York State Common Retirement Fund
ZNTL icon

New York State Common Retirement Fund’s Zentalis Pharmaceuticals ZNTL Stock Holding History

New York State Common Retirement Fund’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,891
Closed -$34.8K – 3357
2025
Q1 		$34.8K Hold
21,891
– – ﹤0.01% 2879
2024
Q4 		$66.3K Hold
21,891
– – ﹤0.01% 2759
2024
Q3 		$80.6K Hold
21,891
– – ﹤0.01% 2695
2024
Q2 		$89.5K Buy
21,891
+9
+0% +$101 ﹤0.01% 2918
2024
Q1 		$345K Sell
21,882
-51
-0.2% -$701 ﹤0.01% 2218
2023
Q4 		$332K Sell
21,933
-80
-0.4% -$1.17K ﹤0.01% 2249
2023
Q3 		$442K Buy
22,013
+250
+1% +$6.35K ﹤0.01% 2108
2023
Q2 		$614K Sell
21,763
-2,231
-9% -$53.5K ﹤0.01% 1986
2023
Q1 		$413K Sell
23,994
-9,704
-29% -$197K ﹤0.01% 2271
2022
Q4 		$679K Buy
33,698
+57
+0.2% +$1.23K ﹤0.01% 2166
2022
Q3 		$729K Sell
33,641
-85,560
-72% -$2.34M ﹤0.01% 2143
2022
Q2 		$3.35M Sell
119,201
-76
-0.1% -$2.01K ﹤0.01% 1387
2022
Q1 		$5.5M Buy
119,277
+1,925
+2% +$104K 0.01% 1241
2021
Q4 		$9.87M Buy
117,352
+93,289
+388% +$7.22M 0.01% 1004
2021
Q3 		$1.6M Sell
24,063
-5,184
-18% -$299K ﹤0.01% 1878
2021
Q2 		$1.56M Buy
29,247
+2,247
+8% +$120K ﹤0.01% 2018
2021
Q1 		$1.17M Buy
27,000
+1,900
+8% +$81.8K ﹤0.01% 2056
2020
Q4 		$1.3M Buy
25,100
+15,600
+164% +$704K ﹤0.01% 1910
2020
Q3 		$311K Hold
9,500
– – ﹤0.01% 2452
2020
Q2 		$456K Buy
+9,500
New +$364K ﹤0.01% 2270

Other funds holding ZNTL

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

New York State Common Retirement Fund's ZNTL Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Zentalis Pharmaceuticals (ZNTL) in Q2 2025, closing a stake of 21,891 shares — an estimated $34.8K sold.

New York State Common Retirement Fund first reported a position in ZNTL in Q2 2020 and held it in 20 quarters. The position peaked at $9.87M in Q4 2021. 117 funds tracked by Wall St. Rank hold ZNTL as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Zentalis Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 21,891 Zentalis Pharmaceuticals shares in Q2 2025, an estimated $34.8K.
  • New York State Common Retirement Fund first reported a position in Zentalis Pharmaceuticals in Q2 2020 and held it in 20 quarters.
  • New York State Common Retirement Fund's Zentalis Pharmaceuticals position peaked at $9.87M in Q4 2021.
  • 117 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.